A study to assess use of anti–vascular endothelial growth factor in the management of retinoblastoma
Latest Information Update: 28 Sep 2020
At a glance
- Drugs Aflibercept (Primary) ; Ranibizumab (Primary)
- Indications Retinal neovascularisation
- Focus Therapeutic Use
- 28 Sep 2020 New trial record